AxioMx Secures $2,000,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0ef93429-686f-4cd1-bc79-f25a8528f555&Preview=1 - Date
12/27/2012 - Company Name
AxioMx - Mailing Address
688 E Main Street Branford, CT 06405 - Company Description
AxioMx has developed synthetic recombinant antibody libraries with greater than ten billion unique clones. Diversity in our libraries is restricted to the most variable positions in the complementarity determining regions (CDRs) of natural antibody sequences. Our antibody frameworks have been optimized for protein expression, and our libraries efficiently generate binders to peptides as well as protein antigens. - Website
http://www.axiomxinc.com - Transaction Type
Venture Equity - Transaction Amount
$2,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
Elm Street Ventures - Venture Investor
Connecticut Innovations
